|
|
|
|
|
|
|
|
|
|
|
Go Play Outside
If at some point this holiday season you find yourself going over the river and through the woods, you might be contributing to a sector that employs 5 million people and attracts $1.2 trillion in consumer spending in the United States.
|
|
|
Read More >>>>
|
|
|
|
|
|
|
|
|
|
|
|
|
ADVERTISEMENT
|
|
|
|
|
Grand Rapids is one of only 25 cities that Good Jobs First says meet transparency expectations.
Photo by Sean Pavone: Getty Images
|
|
|
Last week, Good Jobs First released “Seeing Is Engaging: Economic Development Transparency in Small- and Medium-Sized U.S. Cities,” which covers 229 cities with populations between 50,000 and 350,000 in 45 states. It’s an apt companion to analysis of state incentives program evaluation from experts at Pew Charitable Trusts that was published earlier this month by Site Selection.
“We began rating state governments on subsidy transparency in 2007,” said Good Jobs First Executive Director Greg LeRoy. “Over time, all but one state has moved to having some incentive disclosure and many have greatly improved. Now that cities see that transparency won’t hurt their ‘business climate,’ we are confident they will also up their games.”
|
|
|
|
|
|
|
|
|
DCEO INTERVIEW
Building on Solid Momentum
Kristin Richards, director of the Illinois Department of Commerce and Economic Opportunity, outlines how state government partners with private industry to create expansion opportunities.
|
|
|
|
|
|
|
ADVERTISEMENT
|
|
|
|
|
|
The International Federation of Robotics last week reported that global robot density has doubled in seven years, reaching a record 162 units per 10,000 employees in 2023. The World Robotics 2024 report says the Republic of Korea is the world´s No. 1 adopter of industrial robots with 1,012 robots per 10,000 employees. Next in line come Singapore, China, Germany and Japan.
|
|
|
|
|
|
Photo courtesy of Takeda and Infrareal
|
Last week Takeda and Infrareal signed an agreement that will transfer this Takeda site in Orth, Austria — including buildings, infrastructure and some pharmaceutical production facilities — to Infrareal. The agreement is subject to customary legal and regulatory pre closing conditions including merger control approval in Austria. “Over the last 40 years and more, Orth an der Donau has developed into a center of excellence for the pharmaceutical and life science industries, focusing on gene and cell therapy and biologics,” said Dr. Martin Egger, CEO and spokesperson for the management of Infrareal. “Our expertise will help us to further expand the site, and we are hoping to attract more companies from these industries.” The company noted the attractiveness of Orth to biopharma companies due to the “facilities and infrastructure available at the Pharmapark, its highly qualified employees and its proximity to Vienna International Airport and the Austrian capital.”
|
|
|
|
|
